Skip to content

Depression: all studies

Page 568 of 1,034: studies 5,671 to 5,680 of 10,336, newest first. Back to the depression overview

Research

Evidence that 5-HT2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non-psychedelic drugs.

British Journal of Pharmacology June 22, 2025 Aurelija Ippolito, Sridhar Vasudevan, Shaun Hurley et al. 9 citations

Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5-HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5-HT2A receptor ligand bias or signalling efficacy. Here, we investigated 5-HT2A receptor signalling properties of...

DOI: 10.1111/bph.70109 (opens in new tab) Full text (opens in new tab) 5‐ht2a receptor Biased agonism Psychedelic drugs 5-ht2a receptor pharmacology +15

Mindfulness-Based Stress Reduction adapted to pregnant women with psychosocial vulnerabilities - a randomized feasibility trial in a Danish hospital-based outpatient setting.

Pilot and Feasibility Studies June 21, 2025 Sine Skovbjerg, Michelle Kolls, Anette Kjærbye-Thygesen et al.

Supporting prenatal mental health in women with a preconception history of mental disorders or psychosocial vulnerability is important for a positive transition to parenthood. There is a need for more evidence-based and non-pharmacological mental health interventions in antenatal care. The primary objective of this trial was to evaluate the feasibility of prenatal MBSR, which is an adaption of...

DOI: 10.1186/s40814-025-01670-0 (opens in new tab) Full text (opens in new tab) Feasibility trial Mindfulness-based stress reduction Pregnancy Prenatal mbsr +6

The feasibility of a two-day intensive forest therapy incorporating mindfulness practices for natural disaster-affected individuals: a brief report

Frontiers in Psychology June 20, 2025 Yongjun Lee, Yeji Yang, Ji-Eun Pyo et al.

This study investigated the feasibility and psychological benefits of a two-day intensive forest therapy program incorporating mindfulness practices for individuals affected by natural disasters. The sample comprised 110 participants, including those who had either experienced wildfires or floods or served as first responders. The results revealed significant reductions in depression, anxiety,...

Peer-supported mindfulness-based intervention for managing depressive symptoms in community-dwelling older adults: Protocol for a randomized controlled trial.

Contemporary Clinical Trials June 20, 2025 Yun-Lin Wang, Yun-Han Wang, Dara Kiu Yi Leung et al. 1 citation

Depression in old age is a public health concern contributing to individual and societal burdens. Mindfulness-based stress reduction (MBSR) and mindfulness-based cognitive therapy (MBCT) have shown promise in reducing depressive symptoms. However, time commitments associated with these interventions could pose challenges to older adults. To address this, we propose a briefer mindfulness-based...

DOI: 10.1016/j.cct.2025.107991 (opens in new tab) Full text (opens in new tab) Depressive symptoms Older adults Peer support Social worker +1

A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers.

Journal of Psychopharmacology June 20, 2025 Mutahira Qureshi, Daniel Silman, Romayne Gadelrab et al. 3 citations

Ketamine, a rapid-acting N-methyl-D-aspartate receptor antagonist used as a therapeutic for treatment-resistant depression (TRD), is usually administered intravenously or intranasally. This randomized, double-blind, placebo-controlled, Phase 1 study investigated safety and tolerability (primary endpoint), pharmacokinetics (PK) and pharmacodynamics (PD) of an immediate-release oral ketamine....

Beyond surgery: Repurposing anesthetics for treatment of central nervous system disorders.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 20, 2025 Joana Mielko, Julia Pakulska, Amelia Oszczyk et al.

The development of new drugs is a complex, expensive, and time-consuming process, often fraught with a high likelihood of failure. Amid these obstacles, drug repurposing, which identifies new therapeutic applications for already existing medications, offers a more economical and time-saving approach, particularly in the challenging field of neurological and psychiatric disorders. This narrative...

DOI: 10.1016/j.pnpbp.2025.111386 (opens in new tab) Full text (opens in new tab) Drug repurposing Neurological disorders Neuropsychiatric disorders Anesthetics anaesthetics +5

The association of brain injury severity with dream cessation and nightmares.

Neuropsychologia June 19, 2025 Sam Fisher-Hicks, Victoria Lovett, Rodger Ll Wood et al.

Mesial frontal and temporoparietal brain areas differ in activity between high and low dream recallers, and lesion studies have found cessation of dreaming in patients with damage to these areas. This study extends these findings by assessing the relationship of dream cessation, and dream and nightmare frequencies, to severity of injury in patients at a head trauma clinic. 52 participants (M =...

DOI: 10.1016/j.neuropsychologia.2025.109209 (opens in new tab) Dreaming Humans Brain injuries Glasgow coma scale +10

Meta-Analysis on Predatory Date-Rape Drugs: Pharmacodynamics and Counteractive Studies of Liquid Ecstasy-GHB (y-hydroxybutyrate) and Ecstasy (3, 4-methylenedioxy-N-methamphetamine, or MDMA)

International Journal of Science and Research (IJSR) June 18, 2025 Rajat Ramesh Pithadia, Sheetal Rajan

The purpose of this research is to investigate developing misuse of certain psychotropic substances, depressants, hypnotics & stimulant drugs. The research is intended to generate a uniform understanding over cruel usage of certain drugs; in diminishing attentiveness, reducing senses & disturbing logical / cognitive skills. This guide is essential to understand how predatory drugs initiate...

Genetics of Response to ECT, TMS, Ketamine and Esketamine.

American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics June 17, 2025 Clio E Franklin, Murat Altinay, Kala Bailey et al. 2 citations

Treatment-resistant mood disorders are often managed with intensive interventions that include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), ketamine, and esketamine, but the role of genetics in clinical response to those interventions is yet to be clearly determined. Here, we review the current literature on the genetics of response to these treatment modalities. To...

DOI: 10.1002/ajmg.b.33038 (opens in new tab) Full text (opens in new tab) Esketamine Individualized treatment Tailored therapy Pharmacogenomics +12

A randomised multiple baseline single case experimental design series using CBT to target mechanisms of transdiagnostic dissociation in 16-to-25-year-olds.

PsyArXiv Preprints June 16, 2025 preprint

Dissociative experiences are prevalent in young people, where they are associated with greater clinical severity of co-occurring difficulties and increased risk of self-harm and suicide. Recent research suggests transdiagnostic dissociation plays a role in the development and maintenance of mental health problems such as anxiety, depression and psychosis, and may therefore constitute a novel...

Full text (opens in new tab) Adolescence Cbt Depersonalisation Sced +8